Literature DB >> 21668324

Acute fatty liver of pregnancy: diagnosis, treatment, and outcome based on 35 consecutive cases.

Paulino Vigil-de Gracia1, Carlos Montufar-Rueda.   

Abstract

OBJECTIVE: We describe our experience with the clinical diagnosis, management and, course of patients with acute fatty liver of pregnancy (AFLP).
METHODS: During the period between January 1996 and June 2010, medical records of patients with AFLP were reviewed for symptoms, laboratory findings, clinical course, and maternal and perinatal outcomes. Routine laboratory evaluation included serial measurement of liver function tests, complete blood cell counts, coagulation profile, and renal function tests.
RESULTS: During the study period 35 women had AFLP as the discharge diagnosis. The mean gestational age at delivery was 36 weeks, 39% were nulliparous and 4 had multiple gestation. The most common presenting symptom was nausea/vomiting (88.5%), jaundice (71.4%), and abdominal pain (51.4%). Maternal morbidity included hypoglycemia (94.2%), renal failure (94.2%), coagulopathy (77.1%), ascites (48.5%), and encephalopathy (40%). There were four maternal deaths (11.4%) and five perinatal deaths (12.5%).
CONCLUSION: We found a typical 'AFLP-Triad' in women with AFLP. First (symptoms): nausea/vomiting, jaundice, epigastric pain; second (laboratory): results indicated renal dysfunction, coagulopathy, liver function abnormalities, low glycemia, and third (complications): renal failure, coagulopathy, ascites, and encephalopathy. We recommended that patients with this triad received evaluation to rule out the diagnosis of AFLP.

Entities:  

Mesh:

Year:  2011        PMID: 21668324     DOI: 10.3109/14767058.2010.531325

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  14 in total

1.  Acute fatty liver of pregnancy treated with plasma exchange.

Authors:  Laurel Hartwell; Thomas Ma
Journal:  Dig Dis Sci       Date:  2014-09       Impact factor: 3.199

Review 2.  Immunology of hepatic diseases during pregnancy.

Authors:  Lars Bremer; Christoph Schramm; Gisa Tiegs
Journal:  Semin Immunopathol       Date:  2016-06-20       Impact factor: 9.623

3.  Acute fatty liver of pregnancy: over six months follow-up study of twenty-five patients.

Authors:  Hao-Feng Xiong; Jing-Yuan Liu; Li-Min Guo; Xing-Wang Li
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

4.  Outcomes and risk factors of patients with acute fatty liver of pregnancy: a multicentre retrospective study.

Authors:  Qiang Gao; Xin Qu; Xiukai Chen; Jicheng Zhang; Fen Liu; Suochen Tian; Chunting Wang
Journal:  Singapore Med J       Date:  2018-01-03       Impact factor: 1.858

Review 5.  Acute Fatty Liver Disease of Pregnancy: Updates in Pathogenesis, Diagnosis, and Management.

Authors:  Joy Liu; Tara T Ghaziani; Jacqueline L Wolf
Journal:  Am J Gastroenterol       Date:  2017-03-14       Impact factor: 10.864

Review 6.  Liver diseases in pregnancy: diseases unique to pregnancy.

Authors:  Khulood T Ahmed; Ashraf A Almashhrawi; Rubayat N Rahman; Ghassan M Hammoud; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

Review 7.  Acute Fatty Liver of Pregnancy: Pathophysiology, Anesthetic Implications, and Obstetrical Management.

Authors:  Emily E Naoum; Lisa R Leffert; Hovig V Chitilian; Kathryn J Gray; Brian T Bateman
Journal:  Anesthesiology       Date:  2019-03       Impact factor: 7.892

8.  Acute Fatty Liver of Pregnancy: A Retrospective Analysis of 56 Cases.

Authors:  Yan-Ping Zhang; Wei-Qi Kong; Sheng-Ping Zhou; Yun-Hui Gong; Rong Zhou
Journal:  Chin Med J (Engl)       Date:  2016-05-20       Impact factor: 2.628

9.  Acute Fatty Liver of Pregnancy: A Life-Threatening Condition Requiring a Life-Saving Approach.

Authors:  Mansoureh Gorginzadeh; Saeid Safari; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2016-05-25       Impact factor: 0.660

Review 10.  Liver Disease During Pregnancy: A Challenging Clinical Issue.

Authors:  Ivana Mikolasevic; Tajana Filipec-Kanizaj; Ivan Jakopcic; Iva Majurec; Alemka Brncic-Fischer; Nikola Sobocan; Irena Hrstic; Tea Stimac; Davor Stimac; Sandra Milic
Journal:  Med Sci Monit       Date:  2018-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.